Net margin is calculated as Net Income divided by its Revenue. ScandiDos AB's Net Income for the
three
months ended in Apr. 2026 was kr0.13 Mil. ScandiDos AB's Revenue for the
three
months ended in Apr. 2026 was kr14.15 Mil. Therefore, ScandiDos AB's net margin for the quarter that ended in Apr. 2026 was 0.90%.
The historical rank and industry rank for ScandiDos AB's Net Margin % or its related term are showing as below:
OSTO:SDOS'
s Net Margin % Range Over the Past 10 Years
Min: -36.38 Med: -18.85 Max: 0.53
Current: -6.31
OSTO:SDOS's Net Margin % is ranked worse than 61.08% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.05
vs OSTO:SDOS: -6.31
ScandiDos AB (OSTO:SDOS) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
ScandiDos AB Net Margin % Related Terms
ScandiDos AB Net Margin % Historical Data
* Premium members only.
The historical data trend for ScandiDos AB's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:SDOS vs ABT, SYK, MDT: Net Margin % Comparison
For the Medical Devices subindustry, ScandiDos AB's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ScandiDos AB Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ScandiDos AB's Net Margin % distribution charts can be found below:
* The bar in red indicates where ScandiDos AB's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ScandiDos AB (OSTO:SDOS) has a Net Margin % of 0.90% as of Apr. 2026. Net margin is the ratio of total net income to net sales. View historical data on ScandiDos AB and its competitors. According to the industry distribution chart, ScandiDos AB ranks #499 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 61.1%.
Is ScandiDos AB's Net Margin % too high?
ScandiDos AB's current Net Margin % is 0.90%. The Medical Devices & Instruments industry median Net Margin % is 2.05. ScandiDos AB's value of 0.90% is 56.1% below this industry median. Based on the distribution chart, ScandiDos AB ranks #499 out of 817 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, ScandiDos AB has a GF Score™ of 48/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does ScandiDos AB's Net Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, ScandiDos AB ranks #499 out of 817 companies for Net Margin %. This places ScandiDos AB in the lower half of its industry. The industry median Net Margin % is 2.05. ScandiDos AB's value of 0.90% is 56.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.05, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ScandiDos AB's current Net Margin % of 0.90% is 56.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on ScandiDos AB and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ScandiDos AB's current Net Margin % is 0.90%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ScandiDos AB stock overvalued right now?
Based on GuruFocus' analysis, ScandiDos AB (OSTO:SDOS) is currently considered Possible Value Trap. The stock's GF Value™ is kr1.15, compared to a current price of kr0.80 — trading 30.4% below its estimated fair value. The current Net Margin % is 0.90% and 56.1% below the Medical Devices & Instruments industry median of 2.05. ScandiDos AB's overall GF Score™ is 48/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For ScandiDos AB (OSTO:SDOS), the current Net Margin % is 0.90% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ScandiDos AB (OSTO:SDOS) Overvalued in 2026?
Based on GuruFocus' analysis, ScandiDos AB stock appears to be undervalued.
The current stock price of kr0.80 is trading 30.4% below its estimated GF Value™ of kr1.15.
GuruFocus considers ScandiDos AB to be Possible Value Trap.
Key valuation signals for OSTO:SDOS:
Net Margin %: 0.90%
GF Value™: kr1.15 vs. price of kr0.80 (30.4% below fair value)
Industry Position: 56.1% below the Medical Devices & Instruments median (#499 of 817)
No single metric tells the full story. See the OSTO:SDOS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ScandiDos AB is engaged in providing radiation therapy for cancer. Its product, Delta4 Phantom+, and its various hardware and software options are at the heart of everything ScandiDos does, from product development and production to marketing, sales, and customer support. With Delta4 HexaMotion ScandiDos has successfully developed a motion platform that recreates the movement of the tumor in six dimensions and independently simulates the patient's breathing movement.
48GF Score
Get the complete analysis for OSTO:SDOS
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:SDOS has been successfully added to your 
